Active Motif Signs Global Distribution Deal with Arima Genomics for 3D Genomics Solutions
Active Motif will distribute Arima Genomics' advanced 3D genomics solutions globally under an exclusive agreement, expanding its epigenetics research portfolio.
Active Motif has entered into an exclusive global distribution agreement with Arima Genomics for the latter's 3D genomics solutions. The partnership is set to broaden Active Motif's offerings in genomics research.
The agreement centers on Arima Genomics' proprietary technology for analyzing chromatin's three-dimensional structure. These tools are expected to provide researchers with enhanced capabilities for studying gene expression and regulation.
Arima Genomics stated that the agreement will allow the company to strategically focus on its clinical diagnostics platform. Meanwhile, its technology will gain broader global reach through Active Motif's established customer base.
Active Motif provides epigenetics and multiomic solutions for mechanistic, translational, and clinical research. The company announced the distribution agreement on July 6, 2026.